Aegerion Pharmaceuticals Announces Webcast of Investor Presentations at
CAMBRIDGE, Mass., Feb. 7, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals,
Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the
development and commercialization of novel therapeutics to treat debilitating
and often fatal rare diseases, announced today that the company will
participate in the 15^th Annual BIO CEO & Investor Conference in New York
City. Marc Beer, Chief Executive Officer of Aegerion, is scheduled to present
on Tuesday, February 12, 2013 at 10:30 a.m. ET.
Aegerion will also participate in the Leerink Swann 2013 Global Healthcare
Conference in New York City. Mark Fitzpatrick, Chief Financial Officer of
Aegerion, is scheduled to present on Thursday, February 14, 2013 at 3:00 p.m.
Both presentations will be webcast live and may be accessed for up to 14 days
following the conference by visiting the "Investors" section of Aegerion's
About Aegerion Pharmaceuticals
Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the
development and commercialization of innovative, life-altering therapies for
patients with debilitating, often fatal, rare diseases. For more information
about the company, please visit www.aegerion.com.
The Aegerion Pharmaceuticals, Inc. logo is available at
CONTACT: Aegerion Pharmaceuticals, Inc.
Manager, Investor Relations
Aegerion Pharmaceuticals, Inc. Logo
Press spacebar to pause and continue. Press esc to stop.